Justin E. Bekelman
Papers
2
Total Citations
7
H-Index
2
About
Justin E. Bekelman is a leading health policy researcher and radiation oncologist whose work focuses on the intersection of cancer care delivery, health economics, and the adoption of advanced technologies. His major contributions lie in understanding how policy decisions and market forces shape the use of innovative treatments like stereotactic body radiation therapy (SBRT) for prostate cancer. In his influential 2019 study, he examined whether SBRT adoption is driving overtreatment by expanding the pool of patients who receive radiation instead of opting for active surveillance. His 2015 paper further explored how local coverage determinations (LCDs) and market characteristics influence the diffusion of SBRT, revealing critical insights into the unintended consequences of healthcare regulation. Though his most-cited works have modest citation counts, their impact is significant within the field of radiation oncology policy, informing debates on value-based care and treatment appropriateness. Bekelman’s research is essential for students and clinicians seeking to understand how policy, not just science, shapes cancer treatment patterns in the United States.
Research Focus
Key Achievements
Top Papers
- 1
- 2